Diabetes Care 36 , 34603468 (2013)
The lean mass preservation problem has emerged as perhaps the most pressing clinical concern
Slower systemic results: For musculoskeletal injuries or systemic inflammation, oral dosing may be less effective
Whats interesting is that while it didnt drive trust or intent, it landed in the middle of the pack when it came to shifting perceptions of weight loss treatments overall
Does the drug actually work
Large randomized trials evaluating liraglutide, semaglutide, and dulaglutide consistently demonstrate reductions in major adverse cardiovascular events, including myocardial infarction, stroke, and cardiovascular death